Clinician performing an abdominal ultrasound on a patient
    Regenerative Therapy

    MUSE Cells and Liver Cirrhosis Research

    November 5, 202610 min read

    Why People With Cirrhosis Ask About MUSE Cells

    Cirrhosis can bring tiredness, fluid build-up, itching and frequent hospital visits. Many people ask whether MUSE cells for liver cirrhosis could repair the scarring. The research is interesting, but it is still at the animal stage.

    If you have just been told about a liver finding on a scan, our fatty liver after a scan guide covers the first steps.

    MUSE cells have also been studied in kidney models; see MUSE cell research in kidney disease.

    What Cirrhosis Care Comes Before MUSE Cell Research

    • Treat the cause: alcohol, viral hepatitis, fatty liver disease or others
    • Regular blood tests and imaging
    • Screening for varices and liver cancer
    • Managing fluid, nutrition and medicines
    • Referral for transplant assessment when appropriate

    Vomiting blood, confusion or a swollen, painful abdomen need urgent medical care.

    What MUSE Cell Research in Mice Shows for Cirrhosis

    Iseki and colleagues gave human bone marrow MUSE cells intravenously to immunodeficient mice with chemically induced liver fibrosis. The cells collected mainly in the liver and formed cells with liver markers without fusing with host cells.

    Compared with mice given a vehicle or MSCs with MUSE cells removed, the MUSE group showed recovery in bilirubin and albumin and reduced fibrosis.

    What MUSE Cell Research in Pigs Adds for Cirrhosis

    Nishina and colleagues tested MUSE cells in mini pigs with liver fibrosis (6 MUSE, 6 MSC, 7 vehicle). The MUSE group had higher serum albumin at 4 weeks and improved fibrosis at 12 weeks. No serious adverse effects were observed.

    Evidence levelWhat existsWhat it means for patients
    Mouse modelHoming, liver-like cells, less fibrosisSupports a mechanism, not a human result
    Mini pig modelAlbumin and fibrosis changes, no serious adverse effectsSupports moving towards human studies
    Human trialsNo published result found in our reviewBenefit and safety in people unknown

    MUSE Cell Therapy Approach for Liver Cirrhosis

    • How it works: MUSE cells are proposed to home to the damaged liver and replace injured cells. This is shown in animals only.
    • Who may be suitable: no routine candidate group exists. Anyone interested should look for a registered human study.
    • What a session involves: the animal studies used intravenous injection. A human protocol would need its own dose and monitoring plan.
    • Limits: preclinical evidence. It cannot be offered as a cirrhosis treatment.

    Other cell approaches, such as MSC therapy, have been studied in liver disease, as reviewed by Nishina and colleagues, but each needs its own evidence. Read our MUSE cell therapy overview, MUSE safety evidence and MUSE cells vs iPS cells.

    Questions to Ask About MUSE Cells and Your Liver

    • What stage is my liver disease, and what is causing it?
    • Am I a candidate for transplant assessment?
    • Is there a registered cell study that matches my condition?
    • What would continue in my current care plan?

    Bottom line: MUSE liver research is promising in animals, but it is not a treatment for people with cirrhosis today.

    Medical References

    Talk to a Doctor Before You Decide

    Bring your liver scans, blood results and hepatology letters. Our team can explain what the animal MUSE liver studies can and cannot tell you.

    Schedule a Consultation

    Frequently Asked Questions

    The studies cited here were in mice and mini pigs. We did not find a published human MUSE cirrhosis trial result, so human benefit is unknown.

    In mouse and mini pig liver fibrosis models, MUSE cells reached the liver after intravenous injection, formed liver-like cells, and fibrosis measures improved compared with controls.

    No. Transplant assessment, treating the cause and managing complications remain the established care for advanced cirrhosis.

    The mini pig study reported no serious adverse effects. Animal safety does not establish human safety.

    No. Continue your hepatologist's plan. Cell research does not replace treatment of the underlying cause or complication care.

    Related Articles